Keyword: Calico

AbbVie and Calico reupped their $1.5 billion collaboration on age-related diseases, with a new billion-dollar commitment split between the two.

Chief Scientific Officer Andrew Phillips was named CEO of C4 Therapeutics, a 2016 Fierce 15 winner.

Daphne Koller, an ex-Calico AI expert, plans to enlist data and machine learning to address shortcomings in drug discovery and development. 

Jamie Macdonald succeeds Joseph von Rickenbach as Parexel CEO, Roche promotes William Pao to replace John Reed as pRED head, Moderna loses vaccines head.

Machine learning veteran Daphne Koller is leaving less than two years after joining Calico as chief computing officer.

Hal Barron replaces Patrick Vallance as GSK CSO, Biogen lured Merck exec to head global marketing and Celgene vet Pehl lands at Immunomedics.

Former Roche and Calico vet Hal Barron has become the new CSO and research chief at GlaxoSmithKline amid a shake-up from its new CEO Emma Walmsley.

The financing gives Laura Deming, who started work on the fund before turning 18, $22 million to invest in companies working on age-related diseases.

While you’re searching for, statistically speaking, cat videos, Alphabet’s venture arm GV is searching for life sciences companies that are working on new ways to help people live longer.

Fierce 15 winner C4 Therapeutics has become the latest biopharma to strike a deal with the Google-backed life sciences company Calico, although true to its quiet nature few details about the pact have emerged.